Canonical Wnt target genes (Axin2 and c-Myc) were also upregulated in AD patients, which is consistent with the previously reported role of Mest as a negative regulator of Wnt signaling (Fig. 1e) 7. The gene discussed is MYC; the disease is Alzheimer disease.